These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-003868-30 BTOG2: A British Thoracic Oncology Group phase III trial of gemcitabine plus cisplatin at 80 mg/m2 versus gemcitabine plus cisplatin at 50 mg/m2 versus gemcitabine plus carboplatin AUC 6 in stage IIIB... 2011-04-01 due-trials
Reported results Terminated 2006-005816-29 A Pilot Study of Taxotere (Docetaxel), Cisplatin and 5FU (TPF) in the Palliative Treatment of Squamous Cell Carcinoma of the Head and Neck 2011-02-15 due-trials
Reported results 2007-002169-11 Cost Analysis Of Cetuximab (Erbitux) Plus Radiotherapy (ERT) Versus Concomitant Cisplatin Plus Radiotherapy (CRT) Within An NHS Oncology Unit (New Cross Hospital Wolverhampton): A Pilot Study 2011-09-23 due-trials
Other 2007-004085-41 Photodynamic Therapy for Basal Cell Carcinoma of the Eyelid and Periocular Skin with methyl aminolevulinate not-yet-due
Reported results 2007-005391-13 Cancer Oesophagus Gefitinib(COG) - Phase III randomised, double-blind, placebo-controlled trial of gefitinib (Iressa®) versus placebo in oesophageal cancer progressing after chemotherapy. 2012-05-18 due-trials
Reported results 2012-005666-35 Can Intravenous Iron Reduce Transfusion rates in Anaemic patients undergoing Cardiac Surgery 2016-05-18 due-trials
Reported results 2014-004238-25 Pharmacokinetics and Pharmacodynamics of Platelet P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction: A Pilot Study 2016-11-30 due-trials
Reported results 2016-000195-19 The Effect of Intravenous Cangrelor and Oral Ticagrelor on Platelets, the Microcirculation and Myocardial Damage in Patients admitted with STEMI Treated by Primary Percutaneous Coronary Intervention ... 2018-03-01 due-trials